Down-Regulation of GABAA Receptor via Promiscuity with the Vasoactive Peptide Urotensin II Receptor. Potential Involvement in Astrocyte Plasticity-Reference-Cited by-同舟云学术

Down-Regulation of GABAA Receptor via Promiscuity with the Vasoactive Peptide Urotensin II Receptor. Potential Involvement in Astrocyte Plasticity

Published:2012-05-01 Issue:5 Volume:7 Page:e36319
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Desrues Laurence,Lefebvre Thomas,Lecointre Céline,Schouft Marie-Thérèse,Leprince Jérôme,Compère Vincent,Morin Fabrice,Proust François,Gandolfo Pierrick,Tonon Marie-Christine,Castel Hélène

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference91 articles.

1. Astrocyte-mediated control of cerebral blood flow.;T Takano;Nature neuroscience,2006

2. The neurovascular unit in health and disease: introduction.;EH Lo;Stroke,2009

3. A neurovascular niche for neurogenesis after stroke.;JJ Ohab;The Journal of neuroscience : the official journal of the Society for Neuroscience,2006

4. The astrocyte odyssey.;DD Wang;Prog Neurobiol,2008

5. Astrocyte-endothelial interactions at the blood-brain barrier.;NJ Abbott;Nature reviews Neuroscience,2006

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma;Frontiers in Cell and Developmental Biology;2021-04-14

2. Urotensin II: Molecular Mechanisms of Biological Activity;Current Protein & Peptide Science;2018-07-17

3. Oxidative parameters, oxidative DNA damage, and urotensin-II in schizoaffective disorder patients;Psychiatry and Clinical Psychopharmacology;2018-05-05

4. The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features;Frontiers in Endocrinology;2017-04-25

5. Urotensin-II Receptor: A Double Identity Receptor Involved in Vascocon striction and in the Development of Digestive Tract Cancers and other Tumors;CURR CANCER DRUG TAR;2017